Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
$BTC: Five Reasons Why Bitcoin Could Be a Better Store of Value Than Gold
-
Cryptos Plummet Amidst A Dollar That Leaps On Fed Fears
-
Cryptos Muted Ahead Of Inflation Data, Fed Review
-
MicroStrategy To Purchase More Bitcoin From Proceeds Of A $500 Million Stock Sale
-
BMW Thailand To Use Blockchain Technology For Daily Operations